| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 6e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |